Confirm your regulatory standing first
Before placing an order, clinics typically confirm their current standing with the Michigan Board of Medicine or the licensing board applicable to their practice type, since eligibility to purchase biologic tissue products follows from an active, unrestricted license.
Medspas operating under physician supervision should separately verify that their medical director and supervision arrangement meets Michigan requirements, and should check any state licensing or pharmacy board guidance relevant to handling biologic tissue or exosome products. A final determination on regulatory classification and intended use belongs to the clinic's own legal counsel, not the supplier.
NPI verification and cold-chain delivery
Every Michigan account is checked against the NPPES registry before an order is processed. Once an NPI is confirmed, the account can request lot-specific documentation, including the certificate of analysis, donor eligibility summary, and lot release record, for any product under consideration.
Cryopreserved products ship overnight on dry ice in validated containers to hold -80 degree C storage from release to delivery, and each shipment carries a lot identifier so the receiving clinic can maintain patient-level traceability. These products are not FDA approved or licensed for any disease or condition. Information on this page is for licensed healthcare professionals and is not medical or legal advice.
Where our Michigan accounts are based
Michigan accounts are concentrated around Detroit and Grand Rapids, the state's two largest hubs for orthopedic, pain management, and aesthetic medicine practices.
Across those two cities, NPPES registry data lists approximately 245 orthopedic providers, 261 pain management providers, and 181 aesthetic providers. These figures are registry counts limited to the named cities, not a statewide total, and are not a measure of demand, qualification, or fit for any individual practice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does Precision Biologics ship to Michigan clinics?+
Yes. NPI-verified clinics, physician-supervised medspas, and physicians in Michigan can open an account, and orders ship cold-chain with full lot documentation.
What should a Michigan medspa confirm before ordering?+
Medspas should confirm that their medical director and supervision arrangement meets Michigan requirements, and should check with their own counsel on the regulatory posture of the specific products and intended use.
Are these products stem cell therapies?+
No. The Wharton's jelly products are tissue allografts, and documented commercial cord tissue products are generally not shown to contain viable stem cells. The exosome products are not FDA approved and are not sold as stem cell therapies.